Trial intelligence / Profile preview

Seroquel XR in Acute Bipolar Mania

NCT00422123Phase 3Completed

Sponsor
AstraZeneca
Start
Jan 2007
Countries
1
01

Overview

A Phase 3 trial of quetiapine in bipolar disorder (BD), sponsored by AstraZeneca. Started Jan 2007; status: completed.

02

Drugs

quetiapine
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00422123.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00422123.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call